tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market
EDIT
Editas Medicine
RESEARCH TOOLSreports
Want to see EDIT full AI Analyst Report?

Editas Medicine (EDIT) Ratios

3,557 Followers

Editas Medicine Ratios

EDIT's free cash flow for Q4 2025 was $1.00. For the 2025 fiscal year, EDIT's free cash flow was decreased by $ and operating cash flow was $-0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.22 3.54 3.75 5.39 5.94
Quick Ratio
 3.22 3.54 3.75 5.39 5.94
Cash Ratio
 3.11 3.17 1.70 1.96 2.35
Solvency Ratio
 -0.73 -0.97 -1.12 -0.98 -1.39
Operating Cash Flow Ratio
 -3.53 -3.57 -2.72 -2.09 -2.95
Short-Term Operating Cash Flow Coverage
 -20.97 -14.98 0.00 -11.01 0.00
Net Current Asset Value
$ -16.86M$ 4.65M$ 82.00M$ 190.77M$ 203.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.41 0.10 0.10 0.09
Debt-to-Equity Ratio
 3.92 2.81 0.26 0.14 0.12
Debt-to-Capital Ratio
 0.80 0.74 0.21 0.12 0.11
Long-Term Debt-to-Capital Ratio
 0.71 0.66 0.00 0.00 0.00
Financial Leverage Ratio
 33.88 6.84 2.54 1.43 1.43
Debt Service Coverage Ratio
 -17.10 -8.64 0.00 -13.59 0.00
Interest Coverage Ratio
 40.66 -16.10 0.00 0.00 0.00
Debt to Market Cap
 0.06 0.36 0.00 0.02 0.00
Interest Debt Per Share
 0.15 0.93 0.43 0.64 0.64
Net Debt to EBITDA
 1.39 0.47 0.41 0.46 0.44
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%92.24%67.85%
EBIT Margin
-223.12%-379.79%-739.37%-216.56%-1146.26%
EBITDA Margin
-213.76%-366.76%-721.39%-208.80%-1114.11%
Operating Profit Margin
-251.26%-245.15%-777.22%-216.56%-1146.26%
Pretax Profit Margin
-303.81%-395.01%-733.72%-196.13%-1118.26%
Net Profit Margin
-303.81%-395.01%-733.72%-196.13%-1118.26%
Continuous Operations Profit Margin
-303.81%-395.01%-733.72%-196.13%-1118.26%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
120.91%161.13%94.40%90.57%97.56%
Return on Assets (ROA)
-72.96%-85.81%-69.41%-30.70%-42.86%
Return on Equity (ROE)
-677.39%-586.56%-176.57%-43.89%-61.12%
Return on Capital Employed (ROCE)
-82.25%-70.81%-95.00%-38.81%-49.75%
Return on Invested Capital (ROIC)
-77.51%-65.65%-90.01%-36.77%-48.56%
Return on Tangible Assets
-72.96%-85.81%-69.41%-30.70%-42.86%
Earnings Yield
-35.06%-87.98%-226.73%-19.91%-36.19%
Efficiency Ratios
Receivables Turnover
 13.84 2.67 1.99 7.67 3.83
Payables Turnover
 0.00 0.00 0.00 0.73 0.67
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 1.96 2.06 0.69 1.71 0.33
Asset Turnover
 0.24 0.22 0.09 0.16 0.04
Working Capital Turnover Ratio
 0.35 0.25 0.13 0.27 0.05
Cash Conversion Cycle
 26.38 136.70 183.73 -450.13 -452.55
Days of Sales Outstanding
 26.38 136.70 183.73 47.59 95.27
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 497.72 547.82
Operating Cycle
 26.38 136.70 183.73 47.59 95.27
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.44 -1.86 -2.55 -1.74 -2.58
Free Cash Flow Per Share
 -1.44 -1.87 -2.66 -1.80 -2.64
CapEx Per Share
 <0.01 <0.01 0.11 0.06 0.06
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.04 1.04 1.02
Dividend Paid and CapEx Coverage Ratio
 -240.18 -272.23 -23.83 -28.01 -43.07
Capital Expenditure Coverage Ratio
 -240.18 -272.23 -23.83 -28.01 -43.07
Operating Cash Flow Coverage Ratio
 -8.12 -2.15 -6.00 -2.72 -4.04
Operating Cash Flow to Sales Ratio
 -3.92 -4.08 -6.51 -1.69 -9.00
Free Cash Flow Yield
-45.40%-91.16%-209.54%-17.79%-29.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.85 -1.14 -0.44 -5.02 -2.76
Price-to-Sales (P/S) Ratio
 8.66 4.49 3.24 9.85 30.90
Price-to-Book (P/B) Ratio
 70.50 6.67 0.78 2.20 1.69
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.20 -1.10 -0.48 -5.62 -3.36
Price-to-Operating Cash Flow Ratio
 -2.21 -1.10 -0.50 -5.82 -3.43
Price-to-Earnings Growth (PEG) Ratio
 -0.03 0.03 -0.01 0.14 -0.22
Price-to-Fair Value
 70.50 6.67 0.78 2.20 1.69
Enterprise Value Multiple
 -2.67 -0.75 -0.03 -4.26 -2.33
Enterprise Value
 204.39M 111.99M 8.06M 694.42M 511.48M
EV to EBITDA
 -2.67 -0.75 -0.03 -4.26 -2.33
EV to Sales
 5.70 2.76 0.25 8.89 25.95
EV to Free Cash Flow
 -1.45 -0.68 -0.04 -5.07 -2.82
EV to Operating Cash Flow
 -1.45 -0.68 -0.04 -5.25 -2.88
Tangible Book Value Per Share
 0.05 0.31 1.63 4.60 5.25
Shareholders’ Equity Per Share
 0.05 0.31 1.63 4.60 5.25
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.37 0.46 0.39 1.03 0.29
Net Income Per Share
 -1.11 -1.80 -2.88 -2.02 -3.21
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.36 1.04 0.99 0.91 0.98
Research & Development to Revenue
 1.85 2.22 6.17 2.27 8.88
SG&A to Revenue
 1.30 1.23 2.23 0.89 3.59
Stock-Based Compensation to Revenue
 0.25 0.25 0.66 0.25 1.49
Income Quality
 1.29 1.03 0.89 0.86 0.80
Currency in USD